24 results on '"Turecek, Peter L."'
Search Results
2. Clot formation and fibrinolysis assays reveal functional differences among hemostatic agents in hemophilia A plasma
3. The Nijmegen ultra-sensitive Bethesda Assay detects very low-titer factor VIII inhibitors in patients with congenital and acquired hemophilia A
4. Anti-drug antibodies against the PEG moiety inhibit the procoagulant activity of therapeutic PEGylated FVIII
5. FVIII concentrate half-life heterogeneity in patients with haemophilia A is due to variability in endogenous VWF clearance.
6. Recombinant porcine factor VIII corrects thrombin generation in vitro in plasma from patients with congenital hemophilia A and inhibitors
7. Clinical use of thrombin generation assays
8. Thrombin generation assays are versatile tools in blood coagulation analysis: A review of technical features, and applications from research to laboratory routine
9. Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19
10. Polysialic Acid-Mediated Activity Measurement of Polysialylated Recombinant Coagulation Factor VIII
11. Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factor
12. Issues complicating precision dosing for factor VIII prophylaxis
13. Selective functional activity measurement of a PEGylated protein with a modification-dependent activity assay
14. PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
15. Development of a lectin binding assay to differentiate between recombinant and endogenous proteins in pharmacokinetic studies of protein-biopharmaceuticals
16. PEGylated recombinant von Willebrand factor analyzed by means of MALDI-TOF-MS, CGE-on-a-chip and nES-GEMMA
17. GEMMA and MALDI-TOF MS of reactive PEGs for pharmaceutical applications
18. Convenient high-resolution isoelectric focusing (IEF) method for the separation of alpha1-proteinase inhibitor (A1PI) isoforms in A1PI concentrates
19. In vitro and in vivo anti-retroviral activity of the substance purified from the aqueous extract of Chelidonium majus L.
20. LYSINE TRUNCATION OF ALPHA1-PROTEINASE INHIBITOR UPON DIFFUSION FROM THE VASCULATURE INTO BRONCHEOALVEOLAR LAVAGE
21. PRECLINICAL COMPARISON OF HUMAN ALPHA1-PROTEINASE INHIBITOR FRACTION IV-1 WITH A1PI FROM FRACTION IV-1+4
22. DETECTION OF A NEW ALPHA1-PROTEINASE INHIBITOR ISOFORM MISSING THE C TERMINAL LYSINE IN A HUMAN BRONCHEOALVEOLAR LAVAGE (BAL) SOLUTION
23. DIRECT SENSITIVE ISOELECTRIC FOCUSING (IEF) IMMUNOBLOTTING METHOD FOR THE DETECTION OF THE ALPHA1-PROTEINASE INHIBITOR (A1PI) ISOFORM PATTERN IN DILUTE SOLUTIONS
24. GLYCO-PROTEOMIC ASSESSMENT OF IGG AND ALPHA1-PROTEINASE INHIBITOR (A1PI) FROM A CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENT IN PLASMA AND BRONCHOALVEOLAR LAVAGE FLUID
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.